New research indicates that individuals who come off new GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who stop conventional diet and exercise programs.
Research printed in a prominent health publication points out that while overweight people can lose a large proportion of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing these drugs need to be cognizant of the danger of rapid rebound weight gain when the medication is stopped," cautioned researcher Dr. Susan Jebb.
This pace of recovery implies a return to original mass in about 18 months.
Weighing Therapies
The study, which examined 37 of studies involving over 9,000 of participants, compared the effects of GLP-1 agonists with older methods.
Scientists note that people who shed pounds through lifestyle changes alone usually see a more gradual creep back—approximately 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Doctors suggest the mechanism of the drugs accounts for the accelerated weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating much more probable."
An Ongoing Condition?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals contend that, considering the high risk of relapse, the treatment might need to be long-term.
This view is reinforced by pharmaceutical companies, who state that the results "emphasize the persistent nature of excess weight," akin to managing conditions like hypertension.
User Accounts
People who have stopped the medication report a intense resurgence of appetite.
"It felt as if a trigger that goes on and you become starving," recalled one woman.
This difficulty is compounded if users have not developed permanent dietary or behavioural modifications during treatment.
Growing Interest
Figures indicate that a significant number of adults in the UK have used these injections in the past year, with desire continuing to grow.
- Use is greater among females compared to men.
- The middle-aged demographic shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, clinicians caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone solution and long-term success relies on ongoing lifestyle changes.
